<PAGE> 1
WARBURG PINCUS GROWTH & INCOME FUND
WARBURG PINCUS HEALTH SCIENCES FUND
SUPPLEMENT TO THE PROSPECTUSES AND STATEMENT OF ADDITIONAL INFORMATION
The following replaces certain information contained in the Prospectuses
and Statement of Additional Information of the Funds.
The Growth & Income Fund's Board of Directors recently voted to change the
Fund's name to "Warburg Pincus Value Fund" and its goal to total return. The
Fund will no longer invest in equity securities that are dividend-paying as a
primary strategy, but will continue to invest primarily in equity securities of
value companies. Equity securities of value companies may or may not pay
dividends. These changes will become effective January 1, 2000.
Peter Wen now serves as Co-Portfolio Manager and Research Analyst of the
Health Sciences Fund. Mr. Wen joined Credit Suisse Asset Management, LLC in
1999. From 1994 to 1999, Mr. Wen was an investment analyst with Lynch & Mayer,
Inc. From 1993 to 1994, Mr. Wen was in the MBA Program at the Wharton School of
Business.
Dated: November 1, 1999 16-1199
for
WPUSL
ADGRI
